Inhibikase Therapeutics, Inc. (IKT) › Weighted Average Diluted SharesInhibikase Therapeutics, Inc. (IKT) — Weighted Average Diluted SharesAnnual figures by period end, from SEC filings.2021-12-31: 18.21M2022-12-31: 4.22M2023-12-31: 6.03M2024-12-31: 23.71M2025-12-31: 98.31M98.31M2021-12-31Weighted Average Diluted Shares (shares)2025-12-31Period endedWeighted Average Diluted SharesChange YoYSource filing2025-12-3198.31M+314.6%2026-03-26From 2025-01-012024-12-3123.71M+293.4%2026-03-26From 2024-01-012023-12-316.03M+42.7%2025-03-27From 2023-01-012022-12-314.22M-76.8%2024-03-27From 2022-01-012021-12-3118.21M—2023-03-31From 2021-01-01Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per ShareEPS (Basic)